Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Specification and Evaluation of Plasticizer Migration Simulants for Human Blood Products: A Delphi Study.
Thelliez A, Hénard G, Delorme B, Chatellier S, Danel C, Ducoroy L, Dupont A, Garrigue D, Genay S, Goossens JF, Goossens L, Havet C, Hecq JD, Maeght C, Mendel I, Najdovski T, Odou P, Saint-Lorant G, Ung A, Lecoeur M, Décaudin B. Thelliez A, et al. Among authors: mendel i. Biomolecules. 2021 Jul 22;11(8):1081. doi: 10.3390/biom11081081. Biomolecules. 2021. PMID: 34439748 Free PMC article.
An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment.
Osselaer JC, Cazenave JP, Lambermont M, Garraud O, Hidajat M, Barbolla L, Tardivel R, Defoin L, Waller C, Mendel I, Raidot JP, Kandel G, De Meuter R, Fabrigli P, Dehenau D, Arroyo JL, Padrón F, Gouezec H, Corral M, Jacquet M, Sundin D, Lin L, Corash L. Osselaer JC, et al. Among authors: mendel i. Vox Sang. 2008 May;94(4):315-23. doi: 10.1111/j.1423-0410.2007.01035.x. Epub 2008 Jan 30. Vox Sang. 2008. PMID: 18248574
An active hemovigilance program characterizing the safety profile of 7483 transfusions with plasma components prepared with amotosalen and UVA photochemical treatment.
Cazenave JP, Waller C, Kientz D, Mendel I, Lin L, Jacquet M, Propst M, Liu W, Corash L, Sundin D, Defoin L, Messe N, Osselaer JC. Cazenave JP, et al. Among authors: mendel i. Transfusion. 2010 Jun;50(6):1210-9. doi: 10.1111/j.1537-2995.2009.02579.x. Epub 2010 Jan 22. Transfusion. 2010. PMID: 20113450 Clinical Trial.
Use of additive solutions and pathogen inactivation treatment of platelet components in a regional blood center: impact on patient outcomes and component utilization during a 3-year period.
Cazenave JP, Isola H, Waller C, Mendel I, Kientz D, Laforêt M, Raidot JP, Kandel G, Wiesel ML, Corash L. Cazenave JP, et al. Among authors: mendel i. Transfusion. 2011 Mar;51(3):622-9. doi: 10.1111/j.1537-2995.2010.02873.x. Epub 2010 Sep 16. Transfusion. 2011. PMID: 20849406
Normal B cells express ZAP70 in chronic lymphocytic leukemia: A link between autoimmunity and lymphoproliferation?
Ghergus D, Martin M, Knapp AM, Delmotte F, Joublin-Delavat A, Jung S, Schickel JN, Mendel I, Dupuis A, Drénou B, Ghesquières H, Salles G, Baseggio L, Herbrecht R, Korganow AS, Vallat L, Soulas-Sprauel P, Meffre E, Martin T. Ghergus D, et al. Among authors: mendel i. Am J Hematol. 2024 Jan;99(1):48-56. doi: 10.1002/ajh.27137. Epub 2023 Oct 19. Am J Hematol. 2024. PMID: 37853951
MOSPD2 is a therapeutic target for the treatment of CNS inflammation.
Yacov N, Kafri P, Salem Y, Propheta-Meiran O, Feldman B, Breitbart E, Mendel I. Yacov N, et al. Among authors: mendel i. Clin Exp Immunol. 2020 Aug;201(2):105-120. doi: 10.1111/cei.13448. Epub 2020 May 18. Clin Exp Immunol. 2020. PMID: 32353176 Free PMC article.
Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II study.
Brenner AJ, Peters KB, Vredenburgh J, Bokstein F, Blumenthal DT, Yust-Katz S, Peretz I, Oberman B, Freedman LS, Ellingson BM, Cloughesy TF, Sher N, Cohen YC, Lowenton-Spier N, Rachmilewitz Minei T, Yakov N, Mendel I, Breitbart E, Wen PY. Brenner AJ, et al. Among authors: mendel i. Neuro Oncol. 2020 May 15;22(5):694-704. doi: 10.1093/neuonc/noz231. Neuro Oncol. 2020. PMID: 31844886 Free PMC article. Clinical Trial.
49 results